Human microbiome science: Vision for the future, Bethesda, MD, July 24 to 26, 2013

Microbiome

Volumn 2, Issue 1, 2014, Pages

  Ravel, Jacques ^a   Blaser, Martin J ^b   Braun, Jonathan ^c   Brown, Eric ^d   Bushman, Frederic D ^e   Chang, Eugene B ^f   Davies, Julian ^g   Dewey, Kathryn G ^h   Dinan, Timothy ⁱ   Dominguez Bello, Maria ^b   Erdman, Susan E ^j   Finlay, B Brett ^e   Garrett, Wendy S ^k   Huffnagle, Gary B ^l   Huttenhower, Curtis ^k   Jansson, Janet ^m   Jeffery, Ian B ⁿ   Jobin, Christian ^o   Khoruts, Alexander ^p   Kong, Heidi H ^q   Lampe, Johanna W ^r   Ley, Ruth E ^s   Littman, Dan R ^t,u   Mazmanian, Sarkis K ^v   Mills, David A ^h   Neish, Andrew S ^w   Petrof, Elaine ^x   Relman, David A ^y,z   Rhodes, Rosamond ^aa   Turnbaugh, Peter J ^ab   Young, Vincent B ^l   Knight, Rob ^ac   White, Owen ^a   more..

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ University College Cork and INFANT Centre   (Ireland)

^j MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^m LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

ⁿ UNIVERSITY COLLEGE CORK   (Ireland)

^o UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^p UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^q NATIONAL CANCER INSTITUTE   (United States)

^r Fred Hutchinson Cancer Research Center   (United States)

^s Department of Obstetrics Gynecology   (United States)

^t NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^u Department of Microbiology Molecular Pathogenesis   (United States)

^v CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^w EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^x KINGSTON GENERAL HOSPITAL   (Canada)

^y STANFORD UNIVERSITY   (United States)

^z STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aa MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^ab HARVARD UNIVERSITY   (United States)

^ac UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT; RNA 16S; VACCINE;

ARTICLE; BACTERIA; BIOINFORMATICS; BIOLOGY; DATA ANALYSIS; DIET; DISEASE ASSOCIATION; DRUG EFFICACY; ECOSYSTEM; FECES; GENE EXPRESSION; HOST CELL; HUMAN; IMMUNE SYSTEM; INFECTION; INFLAMMATION; INTESTINE FLORA; LONGITUDINAL STUDY; METABOLITE; METABOLOMICS; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; ORGANISMAL INTERACTION; PHENOTYPE; PRIORITY JOURNAL; PUBLICATION; SYMPOSIUM; TRANSLATIONAL RESEARCH; TRANSPLANTATION;

EID: 84927515653     PISSN: None     EISSN: 20492618     Source Type: Journal    
DOI: 10.1186/2049-2618-2-16     Document Type: Article

References (53)

1. Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, Frabetti F, Vitale L, Pelleri MC, Tassani S, Piva F, Perez-Amodio S, Strippoli P, Canaider S. An estimation of the number of cells in the human body. Annals Human Biol 2013, 40:463-471.
2. Pertea M, Salzberg SL. Between a chicken and a grape: estimating the number of human genes. Genome Biol 2010, 11:206.
3. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977, 31:107-133.
4. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007, 449:804-810.
5. Mikov M. The metabolism of drugs by the gut flora. European J Drug Metabol Pharmacokinet 1994, 19:201-207.
6. Jia W, Li H, Zhao L, Nicholson JK. Gut microbiota: a potential new territory for drug targeting. Nature Rev 2008, 7:123-129.
7. Haiser HJ, Gootenberg DB, Chatman K, Sirasani G, Balskus EP, Turnbaugh PJ. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 2013, 341:295-298.
8. Haiser HJ, Turnbaugh PJ. Is it time for a metagenomic basis of therapeutics?. Science 2012, 336:1253-1255.
9. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS (London, England) 1998, 12:1699-1706.
10. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013, 368:1575-1584.
11. Lyte M. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathogens 2013, 9:e1003726.
12. Group NHW, Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J, et al. The NIH human microbiome project. Genome Res 2009, 19:2317-2323.
13. Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL, Birren BW, Nelson KE, White O, Methe BA, Huttenhower C. The human microbiome project: a community resource for the healthy human microbiome. PLoS Biol 2012, 10:e1001377.
14. Consortium HMP. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214.
15. Consortium HMP. A framework for human microbiome research. Nature 2012, 486:215-221.
16. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008, 6:e280.
17. Lemon KP, Armitage GC, Relman DA, Fischbach MA. Microbiota-targeted therapies: an ecological perspective. Sci Transl Med 2012, 4:137rv135.
18. Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Backhed HK, Gonzalez A, Werner JJ, Angenent LT, Knight R, Backhed F, Isolauri E, Salminen S, Ley RE. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012, 150:470-480.
19. Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UM, Zhong X, Koenig SS, Fu L, Ma ZS, Zhou X, Abdo Z, Forney LJ, Ravel J. Temporal dynamics of the human vaginal microbiota. Sci Translat Med 2012, 4:132ra152.
20. Minot S, Sinha R, Chen J, Li H, Keilbaugh SA, Wu GD, Lewis JD, Bushman FD. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res 2011, 21:1616-1625.
21. Minot S, Bryson A, Chehoud C, Wu GD, Lewis JD, Bushman FD. Rapid evolution of the human gut virome. Proc Natl Acad Sci U S A 2013, 110:12450-12455.
22. Jansson JK, Neufeld JD, Moran MA, Gilbert JA. Omics for understanding microbial functional dynamics. Environ Microbiol 2012, 14:1-3.
23. Lamendella R, VerBerkmoes N, Jansson JK. 'Omics' of the mammalian gut-new insights into function. Curr Opin Biotechnol 2012, 23:491-500.
24. Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol 2012, 30:759-795.
25. Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, Lipuma L, Attur M, Pillinger MH, Weissmann G, Littman DR, Pamer EG, Bretz WA, Abramson SB. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheumatism 2012, 64:3083-3094.
26. Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, Huttenhower C, Littman DR. Expansion of intestinal prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2013, 2:e01202.
27. Segata N, Boernigen D, Tickle TL, Morgan XC, Garrett WS, Huttenhower C. Computational meta'omics for microbial community studies. Mol Syst Biol 2013, 9:666.
28. Yilmaz P, Kottmann R, Field D, Knight R, Cole JR, Amaral-Zettler L, Gilbert JA, Karsch-Mizrachi I, Johnston A, Cochrane G, Vaughan R, Hunter C, Park J, Morrison N, Rocca-Serra P, Sterk P, Arumugam M, Bailey M, Baumgartner L, Birren BW, Blaser MJ, Bonazzi V, Booth T, Bork P, Bushman FD, Buttigieg PL, Chain PS, Charlson E, Costello EK, Huot-Creasy H, et al. Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications. Nat Biotechnol 2011, 29:415-420.
29. Contreras M, Costello EK, Hidalgo G, Magris M, Knight R, Dominguez-Bello MG. The bacterial microbiota in the oral mucosa of rural Amerindians. Microbiol 2010, 156:3282-3287.
30. Blaser MJ, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Estrada I, Gao Z, Clemente JC, Costello EK, Knight R. Distinct cutaneous bacterial assemblages in a sampling of South American Amerindians and US residents. ISME J 2013, 7:85-95.
31. Lee SM, Donaldson GP, Mikulski Z, Boyajian S, Ley K, Mazmanian SK. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 2013, 501:426-429.
32. Young VB, Raffals LH, Huse SM, Vital M, Dai D, Schloss PD, Brulc JM, Antonopoulos DA, Arrieta RL, Kwon JH, Reddy KG, Hubert NA, Grim SL, Vineis JH, Dalal S, Morrison HG, Eren AM, Meyer F, Schmidt TM, Tiedje JM, Chang EB, Sogin ML. Multiphasic analysis of the temporal development of the distal gut microbiota in patients following ileal pouch anal anastomosis. Microbiome 2013, 1:9.
33. Devkota S, Chang EB. Nutrition, microbiomes, and intestinal inflammation. Current Opinion Gastroenterol 2013, 29:603-607.
34. Poutahidis T, Kearney SM, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ, Erdman SE. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One 2013, 8:e78898.
35. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Salcedo R, Kastenmuller W, Deming C, Quinones M, Koo L, Conlan S, Spencer S, Hall JA, Dzutsev A, Kong H, Campbell DJ, Trinchieri G, Segre JA, Belkaid Y. Compartmentalized control of skin immunity by resident commensals. Science 2012, 337:1115-1119.
36. Oh J, Freeman AF, Program NCS, Park M, Sokolic R, Candotti F, Holland SM, Segre JA, Kong HH. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res 2013, 23:2103-2114.
37. Dickson RP, Huang YJ, Martinez FJ, Huffnagle GB. The lung microbiome and viral-induced exacerbations of chronic obstructive pulmonary disease: new observations, novel approaches. Am J Respir Critical Med 2013, 188:1185-1186.
38. Twigg HL, Morris A, Ghedin E, Curtis JL, Huffnagle GB, Crothers K, Campbell TB, Flores SC, Fontenot AP, Beck JM, Huang L, Lynch S, Knox KS, Weinstock G. Lung HIVMP: Use of bronchoalveolar lavage to assess the respiratory microbiome: signal in the noise. Lancet Respir Med 2013, 1:354-356.
39. Neish AS. Redox signaling mediated by the gut microbiota. Free Radical Res 2013, 47:950-957.
40. Jones RM, Luo L, Ardita CS, Richardson AN, Kwon YM, Mercante JW, Alam A, Gates CL, Wu H, Swanson PA, Lambeth JD, Denning PW, Neish AS. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J 2013, 32:3017-3028.
41. Rooks MG, Veiga P, Wardwell-Scott LH, Tickle T, Segata N, Michaud M, Gallini CA, Beal C, van Hylckama-Vlieg JE, Ballal SA, Morgan XC, Glickman JN, Gevers D. Huttenhower C 2014, Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J: Garrett WS, doi:10.1038/ismej.2014.3.
42. Veiga P, Gallini CA, Beal C, Michaud M, Delaney ML, DuBois A, Khlebnikov A. van Hylckama Vlieg JE, Punit S, Glickman JN, Onderdonk A, Glimcher LH, Garrett WS: Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A 2010, 107:18132-18137.
43. Cusack S, O'Toole PW, Consortium E. Challenges and implications for biomedical research and intervention studies in older populations: insights from the ELDERMET study. Gerontology 2013, 59:114-121.
44. Hullar MA, Burnett-Hartman AN, Lampe JW. Gut microbes, diet, and cancer. Cancer Treat Res 2014, 159:377-399.
45. McHardy IH, Goudarzi M, Tong M, Ruegger PM, Schwager E, Weger JR, Graeber TG, Sonnenburg JL, Horvath S, Huttenhower C, McGovern DP, Fornace AJ, Borneman J, Braun J. Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome 2013, 1:17.
46. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012, 13:701-712.
47. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes 2013, 37:16-23.
48. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013, 19:576-585.
49. Arthur JC, Jobin C. The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes 2013, 4:253-258.
50. Davies J, Ryan KS. Introducing the parvome: bioactive compounds in the microbial world. ACS Chem Biol 2012, 7:252-259.
51. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E. Stool substitute transplant therapy for the eradication of clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013, 1:3.
52. Ruiz-Moyano S, Totten SM, Garrido DA, Smilowitz JT, German JB, Lebrilla CB, Mills DA. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of bifidobacterium breve. Appl Environ Microbiol 2013, 79:6040-6049.
53. Hendershot T, Pan H, Haines J, Harlan WR, Junkins HA, Ramos EM, Hamilton CM. Using the PhenX Toolkit to Add Standard Measures to a Study. Current Protocols in Human Genetics 2011, New York: Wiley, Haines JL, Chapter 1:Unit1.21.